- Valuation
- ₹16,870 Cr

About Rainbow Hospitals
Rainbow Hospitals is a publicly listed company based in Hyderabad (India) founded in 1999 by Ramesh Kancharla. A chain of multi-specialty and perinatal care hospitals is operated. Rainbow Hospitals has raised $14.69 million across 3 funding rounds from investors including British International Investment, CDC Group and The Abraaj Group. The company has 4,088 employees. Rainbow Hospitals has completed 1 acquisition, including Prashanthi Hospitals. Rainbow Hospitals was last valued at $186.81 million in February 2016. Its website rainbowhospitals.in draws about 163 thousand monthly visits. Its Indian entity Rainbow Children's Medicare Limited reported revenue of ₹1,747 Cr. Its focus areas include Hospital Chains and Multispecialty Hospital Chains. Its competitors include Narayana Health, Fortis Healthcare and Apollo Hospitals; 1 of its 3 listed competitors has raised funding.
Company details
Founded in 1999 and headquartered in Hyderabad, India, Rainbow Hospitals operates as a chain focused on pediatric and maternity healthcare. Comprehensive services are provided, including NICU and PICU care, emergency and trauma management, pediatric surgery, cardiology, neurology, gastroenterology, endocrinology, hematology, oncology, pulmonology, orthopedics, dentistry, ENT, developmental pediatrics, physiotherapy, and genetic disease management. Operations emphasize multi-specialty perinatal support across its facilities.
Recognitions & Rankings of Rainbow Hospitals
- Market Cap₹13,010 Cr
RAINBOW · NSE
- Share Price₹1,292.70
+0.92% today
- Revenue₹1,703 Cr
FY 2025-26 · +12.4% YoY
- EBITDA₹547 Cr
Margin 32.1%
- Net Profit₹247 Cr
FY 2025-26 · +4.1% YoY
- P/E (TTM)44.2x
P/B 7.6x
- ROE18.1%
ROCE 18.2%
- Debt / Equity0.53
Interest cover 20.7x
- Total Equity Funding$14.69M (USD)
in 3 rounds
- Latest Funding Round$1.62M (USD), Unspecified
Mar 2016
- InvestorsBritish International Investment
& 2 more
- Employee Count4,088
- Investments & Acquisitions
Associated legal entities of Rainbow Hospitals
Rainbow Hospitals is associated with 9 registered companies on The Company Check; the primary company is Rainbow Children's Medicare Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rainbow Children's Medicare Limited Listed CIN L85110TG1998PLC029914 | Active | 07 Aug 1998 | Hyderabad, Telangana | ₹1,747 Cr | 3,418 | 10 | View details |
| Orange Corporation Llp CIN ABC-2995 | Active | 31 Aug 2022 | Hyderabad, Telangana | 2 | View details | ||
| Rainbow C R O Private Limited CIN U73200TG2019PTC136780 | Active | 14 Nov 2019 | Hyderabad, Telangana | ₹0.3 Cr | 3 | View details | |
| Rainbow Fertility Private Limited CIN U85300TG2019PTC134600 | Active | 05 Aug 2019 | Hyderabad, Telangana | ₹0.2 Cr | 2 | View details | |
| Rainbow Hospitals Limited CIN U85110TG1996PLC022939 | Strike Off | 22 Jan 1996 | Hyderabad, Telangana | View details | |||
| Rosewalk Healthcare Private Limited CIN U74900TG2015PTC139548 | Active | 02 Nov 2015 | Hyderabad, Telangana | ₹42.0 Cr | 47 | 4 | View details |
| Rainbow Speciality Hospitals Private Limited CIN U85100TG2010PTC071461 | Active | 30 Nov 2010 | Hyderabad, Telangana, India | View details | |||
| Rainbow Children's Hospital Private Limited CIN U85110TG2010PTC071424 | Active | 29 Nov 2010 | Hyderabad, Telangana, India | View details | |||
| Rainbow Women & Children's Hospital Private Limited CIN U85100TG2010PTC071633 | Active | 13 Dec 2010 | Hyderabad, Telangana, India | View details |
Apps and channels of Rainbow Hospitals
Rainbow Hospitals publishes 2 mobile apps with over 100K+ downloads.
Funding Insights of Rainbow Hospitals
Rainbow Hospitals has successfully raised a total of $14.69M across 3 strategic funding rounds. The most recent funding activity was a Unspecified round of $1.62 million completed in March 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $14.69M
- Total Rounds 3
- Last Round Unspecified — $1.62M
- First Round $17.5M
(Aug 2013)
- Investors Count 3
All 3 funding rounds of Rainbow Hospitals with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2016 | $1.62M | Unspecified | – | – | |
| Feb 2016 | $14.69M | Series B | $186.81M | CDC Group | – |
| Aug 2013 | $17.5M | Unspecified | $93.43M | British International Investment, CDC Group |
| Date | Valuation | Stage |
|---|---|---|
| Feb 2016 | $186.81M | •••••••• |
| Aug 2013 | $93.43M | •••••••• |
Last known valuation $186.81M (Feb 2016). 3 investors in total: 3 institutional.
Investors in Rainbow Hospitals
Rainbow Hospitals has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include British International Investment, CDC Group and The Abraaj Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Private equity investments are managed in emerging markets globally. | abraaj.com | Dubai, United Arab Emirates | ||
Government agency focused on small and medium-sized businesses | 1948 | bii.co.uk | London, United Kingdom | |
Private equity firm focused on emerging markets and impact investing | cdcgroup.com | London, United Kingdom |
Investor details for Rainbow Hospitals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Rainbow Children's Medicare Limited (Rainbow Hospitals)
Rainbow Children's Medicare Limited is the primary company behind Rainbow Hospitals. The boards of the 5 registered companies of Rainbow Hospitals currently have 10 directors; the longest-serving is Anil Dhawan, appointed in 2018. 25 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Anil Dhawan DIN 08191702 | Director | 30 Aug 2018 | 8 yrs 2 mo | Rainbow Children's Medicare Limited |
| Preetham Kumar Poddutoor DIN 08315421 | Director | 18 Jan 2019 | 7 yrs 9 mo | Rosewalk Healthcare Private Limited, Rainbow C R O Private Limited |
| Aluri Rao Srinivasa DIN 00147058 | Director | 15 Mar 2019 | 7 yrs 7 mo | Rainbow Children's Medicare Limited |
| Chirla Padmarao Dinesh Kumar DIN 01395841 | Managing Director | 07 Nov 2019 | 7 yrs | Rosewalk Healthcare Private Limited, Rainbow Fertility Private Limited, Rainbow Children's Medicare Limited |
| Sundari Raviprasad Pisupati DIN 01908852 | Director | 16 Sep 2021 | 5 yrs 1 mo | Rainbow Children's Medicare Limited |
| Santanu Mukherjee DIN 07716452 | Director | 22 Oct 2021 | 5 yrs | Rainbow Children's Medicare Limited |
| Adarsh Kancharla DIN 08302615 | Designated Partner | 31 Aug 2022 | 4 yrs 2 mo | Orange Corporation Llp, Rainbow Children's Medicare Limited |
| Ramesh Kancharla DIN 00212270 | Designated Partner | 31 Aug 2022 | 4 yrs 2 mo | Orange Corporation Llp, Rainbow Fertility Private Limited, Rainbow Children's Medicare Limited |
| . Rakshay DIN 10328310 | Director | 31 Jan 2026 | 9 mo | Rainbow C R O Private Limited |
| Ramesh Konanki DIN 11555778 | Director | 19 Feb 2026 | 8 mo | Rainbow C R O Private Limited |
People of Rainbow Hospitals
35 people are tracked at Rainbow Hospitals (13 in leadership, 22 in team); the tracked headcount is 4,088.
| Name | Role | Group |
|---|---|---|
| Founder | Leadership | |
Vikas Maheshwari | CFO | Leadership |
Neeraj Dhabhai | Vice President Commercial | Leadership |
Ranjini Nair | Vice President | Leadership |
Karuna P | C. Head Quality | Leadership |
Neena Chakraborty | Vice President Human Resources | Leadership |
| Director | Leadership | |
Jeetendra Thakur | Regional Head-business Devlopment | Leadership |
| Whole-time Director | Leadership | |
Suman Yadav | Unit Head ( Talent Acquisition And Culture ) | Leadership |
Saurabh Bhandari | General Manager | Leadership |
Jagan Mohan Reddy | Cluster Head - Nsg Education. | Leadership |
Sachin Mohanty | Head Chef | Leadership |
Amita Naik | Manager- Healthcare Supply Chain Management | Team |
Arnab Das | Assistant Manager | Team |
Ashika Gangamma | Senior Human Resources Manager | Team |
Sharad Shekhar | Engineering Manager | Team |
Ravi Chandra | Seniour Manager Finance Account | Team |
Mahima Angel Robinson | Senior Nurse Educator | Team |
Pattabhi Ram | Information Technology Manager | Team |
15 more people are available in the full profile.
Complete people profiles for Rainbow Hospitals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Rainbow Hospitals
Rainbow Hospitals is a publicly listed company on the NSE with ticker symbol RAINBOW in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date10 May 2022
- Listed onNSE: RAINBOW · BSE: 543524
- Listed entityRainbow Childrens Medicare Limited
- Exchange sectorHealth services
- ISININE961O01016
- Share price₹1,225.90 (+0.76% on the day) · 2026-10-14
- Market capitalisation₹12,370 Cr
- Price to earnings43.6
- EPS (diluted, trailing year)₹28.10
- Dividend yield0.29%
- Volume (last session)106,107
Financials of Rainbow Hospitals
Exchange-reported figures of Rainbow Children's Medicare Limited, the listed company behind Rainbow Hospitals (NSE: RAINBOW).
Financial Highlights
FY 2025-26 · ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,703 | 1,516 | 1,297 | 1,174 | 974 | 650 | 719 |
| Revenue growth | +12.4% | +16.9% | +10.5% | +20.5% | +49.8% | -9.6% | - |
| EBITDA | 547 | 494 | 432 | 400 | 308 | 165 | 201 |
| EBITDA margin | +32.1% | +32.6% | +33.3% | +34.1% | +31.6% | +25.4% | +27.9% |
| Profit before tax | 358 | 330 | 295 | 282 | 187 | 55.70 | 93.37 |
| Net profit | 247 | 238 | 211 | 211 | 138 | 39.96 | 55.71 |
| Net profit margin | +14.5% | +15.7% | +16.3% | +17.9% | +14.2% | +6.2% | +7.7% |
| EPS (₹) | 27.41 | 23.97 | 21.38 | 20.77 | 14.70 | 9.10 | 12.52 |
| Balance sheet | |||||||
| Total assets | 2,614 | 2,248 | 2,038 | 1,642 | 1,193 | 972 | 907 |
| Net worth | 1,648 | 1,468 | 1,259 | 1,060 | 603 | 446 | 405 |
| Total debt | 891 | 764 | 765 | 570 | 581 | 518 | 490 |
| Cash & bank | 33.89 | 20.28 | 10.13 | 47.06 | 185 | 94.67 | 97.24 |
| Net working capital | 97.45 | 123 | 182 | 291 | 165 | 77.96 | 85.45 |
| Cash flow | |||||||
| Cash from operations | 420 | 396 | 321 | 329 | 224 | 143 | 170 |
| Cash from investing | (259) | (268) | (226) | (465) | (175) | (82.88) | (117) |
| Cash from financing | (147) | (118) | (102) | 143 | (44.06) | (60.87) | (51.81) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 548 | 470 | 460 | 445 | 445 | 353 | 370 | 398 |
| Revenue growth (YoY) | +23.2% | +33.2% | +24.3% | +11.9% | +6.6% | +6.9% | - | - |
| Other income | 8.13 | 12.71 | 5.06 | 10.51 | 8.20 | 20.02 | 14.53 | 13.27 |
| EBITDA | 170 | 135 | 143 | 147 | 149 | 104 | 115 | 134 |
| EBITDA margin | +31.0% | +28.6% | +31.1% | +33.0% | +33.5% | +29.4% | +31.0% | +33.7% |
| Depreciation | 44.61 | 42.20 | 40.94 | 39.60 | 35.84 | 34.19 | 34.16 | 35.23 |
| Interest | 22.00 | 21.21 | 20.50 | 20.20 | 18.85 | 18.08 | 18.12 | 18.07 |
| Profit before tax | 112 | 83.95 | 86.78 | 97.69 | 102 | 71.37 | 76.98 | 94.32 |
| Tax | 27.61 | 21.41 | 8.57 | 23.80 | 26.74 | 17.57 | 20.42 | 25.39 |
| Net profit | 83.89 | 62.54 | 78.21 | 73.89 | 75.64 | 53.80 | 56.56 | 68.93 |
| EPS (₹) | 8.10 | 5.97 | 7.59 | 7.14 | 7.41 | 5.27 | 5.55 | 6.76 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | 1,546 | 1,455 | 1,237 | 1,114 | 925 | 614 | 695 |
| Revenue growth | +6.3% | +17.6% | +11.0% | +20.5% | +50.5% | -11.6% | - |
| EBITDA | 502 | 479 | 417 | 380 | 299 | 166 | 209 |
| EBITDA margin | +32.5% | +32.9% | +33.7% | +34.2% | +32.3% | +27.0% | +30.0% |
| Profit before tax | 334 | 322 | 289 | 273 | 190 | 65.89 | 109 |
| Net profit | 219 | 232 | 209 | 209 | 142 | 49.38 | 70.84 |
| Net profit margin | +14.2% | +15.9% | +16.9% | +18.8% | +15.3% | +8.0% | +10.2% |
| EPS (₹) | 24.62 | 23.40 | 21.17 | 20.28 | 15.13 | 11.24 | 15.97 |
| Balance sheet | |||||||
| Total assets | 2,506 | 2,232 | 2,027 | 1,633 | 1,190 | 966 | 902 |
| Net worth | 1,689 | 1,489 | 1,285 | 1,088 | 636 | 476 | 426 |
| Total debt | 801 | 734 | 735 | 538 | 548 | 484 | 469 |
| Cash & bank | 17.29 | 16.91 | 7.49 | 37.15 | 175 | 84.76 | 94.32 |
| Net working capital | 82.52 | 114 | 171 | 288 | 162 | 106 | 116 |
| Cash flow | |||||||
| Cash from operations | 381 | 385 | 306 | 316 | 214 | 142 | 178 |
| Cash from investing | (241) | (263) | (214) | (460) | (169) | (86.79) | (123) |
| Cash from financing | (139) | (113) | (97.00) | 148 | (41.13) | (56.43) | (54.26) |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 487 | 411 | 408 | 394 | 408 | 335 | 354 | 382 |
| Revenue growth (YoY) | +19.2% | +22.6% | +15.3% | +3.4% | +1.1% | +6.3% | - | - |
| Other income | 8.09 | 12.76 | 5.24 | 10.76 | 8.17 | 19.29 | 13.90 | 12.85 |
| Total expenses | 336 | 296 | 281 | 264 | 268 | 235 | 243 | 251 |
| EBITDA | 151 | 115 | 127 | 131 | 141 | 99.52 | 111 | 130 |
| EBITDA margin | +31.1% | +27.9% | +31.2% | +33.1% | +34.4% | +29.7% | +31.3% | +34.1% |
| Depreciation | 39.81 | 37.63 | 35.65 | 34.83 | 33.18 | 32.59 | 32.55 | 33.54 |
| Interest | 19.91 | 19.25 | 18.52 | 18.17 | 17.31 | 17.39 | 17.42 | 17.35 |
| Profit before tax | 99.86 | 70.54 | 78.46 | 88.44 | 98.40 | 68.83 | 74.75 | 92.12 |
| Tax | 24.77 | 17.84 | 19.16 | 22.61 | 25.23 | 17.10 | 20.21 | 25.14 |
Financial Statements
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 548 | 470 | 460 | 445 | 445 | 353 | 370 | 398 |
| Revenue growth (YoY) | +23.2% | +33.2% | +24.3% | +11.9% | +6.6% | +6.9% | - | - |
| Other income | 8.13 | 12.71 | 5.06 | 10.51 | 8.20 | 20.02 | 14.53 | 13.27 |
| EBITDA | 170 | 135 | 143 | 147 | 149 | 104 | 115 | 134 |
| EBITDA margin | +31.0% | +28.6% | +31.1% | +33.0% | +33.5% | +29.4% | +31.0% | +33.7% |
| Depreciation | 44.61 | 42.20 | 40.94 | 39.60 | 35.84 | 34.19 | 34.16 | 35.23 |
| Interest | 22.00 | 21.21 | 20.50 | 20.20 | 18.85 | 18.08 | 18.12 | 18.07 |
| Profit before tax | 112 | 83.95 | 86.78 | 97.69 | 102 | 71.37 | 76.98 | 94.32 |
| Tax | 27.61 | 21.41 | 8.57 | 23.80 | 26.74 | 17.57 | 20.42 | 25.39 |
| Net profit | 83.89 | 62.54 | 78.21 | 73.89 | 75.64 | 53.80 | 56.56 | 68.93 |
| EPS (₹) | 8.10 | 5.97 | 7.59 | 7.14 | 7.41 | 5.27 | 5.55 | 6.76 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,703 | 1,516 | 1,297 | 1,174 | 974 | 650 | 719 |
| Revenue growth | +12.4% | +16.9% | +10.5% | +20.5% | +49.8% | -9.6% | - |
| Other income | 43.79 | 51.01 | 37.06 | 30.87 | 18.94 | 10.26 | 10.35 |
| Total expenses | 1,156 | 1,022 | 865 | 774 | 666 | 485 | 519 |
| Employee cost | 234 | 206 | 176 | 144 | 116 | 102 | 109 |
| EBITDA | 547 | 494 | 432 | 400 | 308 | 165 | 201 |
| EBITDA margin | +32.1% | +32.6% | +33.3% | +34.1% | +31.6% | +25.4% | +27.9% |
| Depreciation | 151 | 138 | 112 | 90.27 | 83.26 | 73.34 | 69.41 |
| Interest | 81.89 | 76.81 | 62.53 | 58.39 | 56.17 | 46.37 | 48.26 |
| Profit before tax | 358 | 330 | 295 | 282 | 187 | 55.70 | 93.37 |
| Tax | 76.69 | 85.78 | 76.53 | 69.40 | 48.67 | 16.13 | 38.02 |
| Net profit | 247 | 238 | 211 | 211 | 138 | 39.96 | 55.71 |
| Net profit margin | +14.5% | +15.7% | +16.3% | +17.9% | +14.2% | +6.2% | +7.7% |
| EPS (₹) | 27.41 | 23.97 | 21.38 | 20.77 | 14.70 | 9.10 | 12.52 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 102 | 102 | 102 | 102 | 105 | 54.90 | 54.90 |
| Reserves & surplus | 1,568 | 1,367 | 1,157 | 958 | 498 | 391 | 350 |
| Shareholders' funds (net worth) | 1,648 | 1,468 | 1,259 | 1,060 | 603 | 446 | 405 |
| Minority interest | 15.51 | 6.82 | 5.99 | 5.01 | 3.46 | 2.01 | 3.91 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 39.81 | 40.52 | 57.68 |
| Unsecured loans | 891 | 764 | 765 | 570 | 541 | 478 | 433 |
| Total debt | 891 | 764 | 765 | 570 | 581 | 518 | 490 |
| Total liabilities | 2,614 | 2,248 | 2,038 | 1,642 | 1,193 | 972 | 907 |
| Assets | |||||||
| Gross block | 2,546 | 2,042 | 1,759 | 1,323 | 1,159 | 997 | 854 |
| Net block | 1,756 | 1,398 | 1,253 | 931 | 858 | 772 | 702 |
| Capital work in progress | 79.22 | 28.46 | 19.90 | 22.79 | 5.76 | 28.77 | 42.75 |
| Investments | 404 | 571 | 308 | 58.14 | 22.10 | 18.27 | 9.90 |
| Inventories | 41.63 | 27.57 | 23.98 | 18.76 | 14.82 | 10.10 | 15.98 |
| Sundry debtors | 103 | 77.30 | 70.44 | 51.20 | 40.41 | 43.97 | 43.96 |
| Cash & bank balances | 33.89 | 20.28 | 10.13 | 47.06 | 185 | 94.67 | 97.24 |
| Loans & advances | 79.65 | 126 | 210 | 303 | 27.66 | 38.12 | 35.52 |
| Total current assets | 258 | 251 | 314 | 420 | 268 | 187 | 193 |
| Total current liabilities | 161 | 129 | 132 | 128 | 103 | 109 | 107 |
| Net working capital | 97.45 | 123 | 182 | 291 | 165 | 77.96 | 85.45 |
| Total assets | 2,614 | 2,248 | 2,038 | 1,642 | 1,193 | 972 | 907 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 20.26 | 10.12 | 16.97 | 9.98 | 5.66 | 6.70 | 5.13 |
| Net cash from operating activities | 420 | 396 | 321 | 329 | 224 | 143 | 170 |
| Net cash from investing activities | (259) | (268) | (226) | (465) | (175) | (82.88) | (117) |
| Net cash from financing activities | (147) | (118) | (102) | 143 | (44.06) | (60.87) | (51.81) |
| Net change in cash | 13.64 | 10.14 | (6.85) | 6.99 | 4.32 | (1.04) | 1.56 |
| Closing cash | 33.89 | 20.28 | 10.13 | 47.06 | 185 | 94.67 | 97.24 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +12.4% | +16.9% | +10.5% | +20.5% | +49.8% | -9.6% | - |
| EBITDA growth | +10.7% | +14.3% | +8.2% | +29.8% | +86.4% | -17.7% | - |
| PBT growth | +8.6% | +11.9% | +4.6% | +50.4% | +236.4% | -40.3% | +62.4% |
| Net income growth | +4.1% | +12.4% | +0.4% | +52.8% | +244.8% | -28.3% | - |
| Revenue CAGR (3Y) | +13.2% | +15.9% | +25.9% | +17.7% | +21.5% | +17.4% | +30.8% |
| EBITDA CAGR (3Y) | +11.0% | +17.1% | +37.8% | +25.8% | +26.7% | +33.5% | +54.0% |
| Profitability & leverage | |||||||
| Net income margin | +16.5% | +16.1% | +16.8% | +18.1% | +14.2% | +6.1% | +7.7% |
| Return on capital employed | +18.2% | +19.0% | +19.5% | +24.1% | +22.6% | +10.9% | +16.2% |
| Return on net worth | +18.1% | +17.9% | +18.8% | +25.7% | +27.0% | +9.5% | +14.5% |
| Debt / equity | 0.53 | 0.56 | 0.58 | 0.69 | 1.05 | 1.18 | 1.23 |
| Long-term debt / equity | 0.52 | 0.55 | 0.56 | 0.67 | 1.01 | 1.14 | 1.19 |
| Interest cover | 20.66 | 21.59 | 19.52 | 18.88 | 25.01 | 50.51 | 36.76 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.74 | 0.80 | 0.84 | 0.95 | 0.90 | 0.70 | 0.87 |
| Inventory turnover | 49.22 | 58.81 | 60.69 | 69.90 | 78.15 | 49.85 | 62.61 |
| Debtors turnover | 18.87 | 20.52 | 21.32 | 25.62 | 23.08 | 14.79 | 18.23 |
| EPS (₹) | 27.41 | 23.97 | 21.38 | 20.77 | 14.70 | 9.10 | 12.52 |
| Dividend per share (₹) | 3.50 | 3.00 | 3.00 | 3.00 | 2.00 | 0.00 | 2.00 |
| Book value per share (₹) | 164.37 | 144.58 | 124.03 | 104.42 | 62.93 | 99.05 | 89.73 |
| Particulars | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 487 | 411 | 408 | 394 | 408 | 335 | 354 | 382 |
| Revenue growth (YoY) | +19.2% | +22.6% | +15.3% | +3.4% | +1.1% | +6.3% | - | - |
| Other income | 8.09 | 12.76 | 5.24 | 10.76 | 8.17 | 19.29 | 13.90 | 12.85 |
| Total expenses | 336 | 296 | 281 | 264 | 268 | 235 | 243 | 251 |
| EBITDA | 151 | 115 | 127 | 131 | 141 | 99.52 | 111 | 130 |
| EBITDA margin | +31.1% | +27.9% | +31.2% | +33.1% | +34.4% | +29.7% | +31.3% | +34.1% |
| Depreciation | 39.81 | 37.63 | 35.65 | 34.83 | 33.18 | 32.59 | 32.55 | 33.54 |
| Interest | 19.91 | 19.25 | 18.52 | 18.17 | 17.31 | 17.39 | 17.42 | 17.35 |
| Profit before tax | 99.86 | 70.54 | 78.46 | 88.44 | 98.40 | 68.83 | 74.75 | 92.12 |
| Tax | 24.77 | 17.84 | 19.16 | 22.61 | 25.23 | 17.10 | 20.21 | 25.14 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Revenue | 1,546 | 1,455 | 1,237 | 1,114 | 925 | 614 | 695 |
| Revenue growth | +6.3% | +17.6% | +11.0% | +20.5% | +50.5% | -11.6% | - |
| Other income | 43.45 | 48.95 | 36.95 | 31.23 | 20.82 | 11.95 | 11.93 |
| Total expenses | 1,044 | 976 | 820 | 734 | 626 | 449 | 486 |
| Employee cost | 212 | 198 | 169 | 136 | 109 | 96.10 | 102 |
| EBITDA | 502 | 479 | 417 | 380 | 299 | 166 | 209 |
| EBITDA margin | +32.5% | +32.9% | +33.7% | +34.2% | +32.3% | +27.0% | +30.0% |
| Depreciation | 136 | 132 | 105 | 83.71 | 76.99 | 67.90 | 64.93 |
| Interest | 75.14 | 73.68 | 59.33 | 55.09 | 52.80 | 43.83 | 46.50 |
| Profit before tax | 334 | 322 | 289 | 273 | 190 | 65.89 | 109 |
| Tax | 84.10 | 84.50 | 74.32 | 66.94 | 47.45 | 16.48 | 38.29 |
| Net profit | 219 | 232 | 209 | 209 | 142 | 49.38 | 70.84 |
| Net profit margin | +14.2% | +15.9% | +16.9% | +18.8% | +15.3% | +8.0% | +10.2% |
| EPS (₹) | 24.62 | 23.40 | 21.17 | 20.28 | 15.13 | 11.24 | 15.97 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Equity & liabilities | |||||||
| Share capital | 102 | 102 | 102 | 102 | 105 | 54.90 | 54.91 |
| Reserves & surplus | 1,584 | 1,387 | 1,184 | 987 | 531 | 421 | 371 |
| Shareholders' funds (net worth) | 1,689 | 1,489 | 1,285 | 1,088 | 636 | 476 | 426 |
| Secured loans | 0.00 | 0.00 | 0.00 | 0.00 | 39.81 | 40.52 | 50.02 |
| Unsecured loans | 801 | 734 | 735 | 538 | 508 | 444 | 419 |
| Total debt | 801 | 734 | 735 | 538 | 548 | 484 | 469 |
| Total liabilities | 2,506 | 2,232 | 2,027 | 1,633 | 1,190 | 966 | 902 |
| Assets | |||||||
| Gross block | 2,196 | 1,974 | 1,693 | 1,259 | 1,096 | 935 | 809 |
| Net block | 1,458 | 1,368 | 1,219 | 891 | 813 | 722 | 663 |
| Capital work in progress | 79.13 | 28.36 | 19.92 | 22.81 | 5.76 | 28.77 | 42.63 |
| Investments | 589 | 596 | 346 | 105 | 42.27 | 36.79 | 24.18 |
| Inventories | 29.91 | 22.74 | 22.59 | 17.67 | 13.88 | 9.29 | 14.62 |
| Sundry debtors | 100 | 78.46 | 71.56 | 50.94 | 41.27 | 45.45 | 36.54 |
| Cash & bank balances | 17.29 | 16.91 | 7.49 | 37.15 | 175 | 84.76 | 94.32 |
| Loans & advances | 77.65 | 118 | 193 | 302 | 27.47 | 70.33 | 75.24 |
| Total current assets | 225 | 236 | 295 | 408 | 258 | 210 | 221 |
| Total current liabilities | 143 | 122 | 123 | 120 | 95.80 | 104 | 104 |
| Net working capital | 82.52 | 114 | 171 | 288 | 162 | 106 | 116 |
| Total assets | 2,506 | 2,232 | 2,027 | 1,633 | 1,190 | 966 | 902 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Opening cash | 16.89 | 7.49 | 11.79 | 8.83 | 4.32 | 5.99 | 4.97 |
| Net cash from operating activities | 381 | 385 | 306 | 316 | 214 | 142 | 178 |
| Net cash from investing activities | (241) | (263) | (214) | (460) | (169) | (86.79) | (123) |
| Net cash from financing activities | (139) | (113) | (97.00) | 148 | (41.13) | (56.43) | (54.26) |
| Net change in cash | 0.39 | 9.41 | (4.31) | 2.96 | 3.73 | (1.67) | 1.02 |
| Closing cash | 17.29 | 16.91 | 7.49 | 37.15 | 175 | 84.76 | 94.32 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|---|---|
| Growth | |||||||
| Sales growth | +6.3% | +17.6% | +11.0% | +20.5% | +50.5% | -11.6% | - |
| EBITDA growth | +4.9% | +14.8% | +9.6% | +27.4% | +80.3% | -20.6% | - |
| PBT growth | +3.7% | +11.4% | +6.0% | +43.8% | +188.0% | -39.6% | +37.6% |
| Net income growth | -5.5% | +10.7% | +0.2% | +47.3% | +187.1% | -30.3% | - |
| Revenue CAGR (3Y) | +11.5% | +16.3% | +26.3% | +17.0% | +19.4% | +15.2% | +43.8% |
| EBITDA CAGR (3Y) | +9.7% | +17.0% | +36.0% | +22.2% | +38.5% | +33.6% | +91.6% |
| Profitability & leverage | |||||||
| Net income margin | +16.2% | +16.3% | +17.4% | +18.5% | +15.4% | +8.0% | +10.2% |
| Return on capital employed | +17.3% | +18.6% | +19.0% | +23.2% | +22.5% | +11.8% | +22.7% |
| Return on net worth | +15.7% | +17.1% | +18.1% | +24.0% | +26.1% | +11.2% | +17.2% |
| Debt / equity | 0.48 | 0.53 | 0.54 | 0.63 | 0.93 | 1.06 | 0.62 |
| Long-term debt / equity | 0.47 | 0.52 | 0.53 | 0.61 | 0.90 | 1.02 | 0.59 |
| Interest cover | 20.54 | 21.25 | 19.04 | 18.57 | 23.81 | 44.83 | 32.35 |
| Efficiency & per share | |||||||
| Fixed asset turnover | 0.74 | 0.79 | 0.84 | 0.95 | 0.91 | 0.70 | 1.14 |
| Inventory turnover | 58.71 | 64.17 | 61.43 | 70.62 | 79.81 | 51.40 | 64.45 |
| Debtors turnover | 17.29 | 19.39 | 20.19 | 24.16 | 21.32 | 14.99 | 21.36 |
| EPS (₹) | 24.62 | 23.40 | 21.17 | 20.28 | 15.13 | 11.24 | 15.97 |
| Dividend per share (₹) | 3.50 | 3.00 | 3.00 | 3.00 | 2.00 | 0.00 | 2.00 |
| Book value per share (₹) | 165.94 | 146.58 | 126.62 | 107.23 | 66.49 | 105.78 | 94.33 |
Investments & Acquisitions by Rainbow Hospitals
Rainbow Hospitals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Prashanthi Hospitals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Provider of women's and children's healthcare services | prashanthihospitals.com | Warangal, India | 2009 | Jun 2025 | •••• |
Complete acquisition details for Rainbow Hospitals
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Rainbow Hospitals
6 dated milestones of Rainbow Hospitals across 26 years, from founding to its latest funding, stage changes and deals.
- Founded Rainbow Hospitals is founded.
- Funding First funding round of $17.5M.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Unspecified, of $1.6M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Prashanthi Hospitals.
Competitors of Rainbow Hospitals
Rainbow Hospitals has 3 listed competitors in our database, 1 of them funded. They include Narayana Health, Fortis Healthcare and Apollo Hospitals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| narayanahealth.org | 2000 | Bengaluru, India | $148.2M | 8,145 | A chain of multi-specialty hospitals is operated in India. | |
| fortishealthcare.com | 1996 | Gurugram, India | 1,565 | Multi-specialty hospital services are provided across India by Fortis Healthcare. | ||
| apollohospitals.com | 1983 | Chennai, India | 21,350 | Chain of multispecialty hospitals |
Detailed competitors of Rainbow Hospitals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Rainbow Hospitals
The website of Rainbow Hospitals (rainbowhospitals.in) receives about 162.5K visits a month and ranks #240,366 among all websites worldwide, #8,042 in Health.
- Monthly visits162.5K
▲ 22.2% vs previous month
- Unique visitors62.2K
per month
- Global rank#240,366
among all websites
- Category rank#8,042
Health · Health
- Bounce rate24%
- Pages per visit4.4
- Average visit1 min 47 sec
- DevicesDesktop 12% · Mobile 88%
Websites whose visitors overlap most with Rainbow Hospitals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
docsuggest.com | docsuggest.com | 100% | – | ||
| ankurahospitals.com | 87% | 128.5K | #199,483 | View details | |
| kaminenihospitals.com | 83% | 14.7K | #1,559,835 | View details | |
asterhospitals.in | asterhospitals.in | 81% | #108,274 | – | |
| askapollo.com | 81% | 3.5K | #6,047,344 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Rainbow Hospitals
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Hospitals & Clinical Care
3 companies that operate in the same segment as Rainbow Hospitals (Hospitals & Clinical Care) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Maternity, childcare, and fertility services are delivered via hospital chains. | 2007 | Bengaluru, Karnataka, India | USD 204.87 M | USD 140.46 M | 4,459 | |
Chain of oncology hospitals | 1989 | Bengaluru, Karnataka, India | USD 36.59 M | USD 270.51 M | 321 | |
Chain of multi-super specialty healthcare hospitals | 2004 | Gurugram, Haryana, India | USD 104.7 M | USD 461.72 M | 12,240 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Rainbow Hospitals
Complete news archive for Rainbow Hospitals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rainbow Hospitals
Rainbow Hospitals was founded in 1999 and raised its 1st funding round 14 years after it was founded.
Rainbow Hospitals is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Rainbow Hospitals is a funded company, having raised a total of $14.69M across 3 funding rounds to date. The company's 1st funding round was a Unspecified of $17.5M, raised on Aug 2013.
Rainbow Hospitals has 4,088 employees.
The primary company behind Rainbow Hospitals, Rainbow Children's Medicare Limited, reported revenue of ₹1,747 Cr for FY 2026, up 12% year on year.
Founded in 1999 and headquartered in Hyderabad, India, Rainbow Hospitals operates as a chain focused on pediatric and maternity healthcare. Comprehensive services are provided, including NICU and PICU care, emergency and trauma management, pediatric surgery, cardiology, neurology, gastroenterology, endocrinology, hematology, oncology, pulmonology, orthopedics, dentistry, ENT, developmental pediatrics, physiotherapy, and genetic disease management. Operations emphasize multi-specialty perinatal support across its facilities.
Rainbow Hospitals's top competitors include Fortis Healthcare, Apollo Hospitals and Narayana Health.
Yes, Rainbow Hospitals is publicly traded on NSE under the ticker symbol RAINBOW.
Rainbow Hospitals has made 1 acquisition, including Prashanthi Hospitals.
Rainbow Hospitals has 3 investors. Key investors include British International Investment, CDC Group, and The Abraaj Group.
The valuation of Rainbow Hospitals is $186.81M as of Feb 2016.
Rainbow Hospitals is associated with 6 legal entities: Rainbow Children's Medicare Limited, Orange Corporation Llp, Rosewalk Healthcare Private Limited and others.
